The tool that makes this possible is the beam profiler, which captures a two-dimensional plot of the intensity of a laser beam. Although many people might imagine that the power density of a laser ...

What risks are associated with the safety profile of Beam's therapies? The safety profile of Beam's base editing therapies remains a critical concern for investors and regulators alike.

Beam Therapeutics Inc . (NASDAQ:BEAM), a $2.1 billion market cap pioneer in the field of precision genetic medicines through base editing, is set to present new data from its ongoing BEACON Phase 1/2 ...

Blue Trust Inc. increased its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 36.3% during the ...

Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising preclinical BEAM-103 results. Cathie Wood, CEO of ARK Invest, is doubling ...